Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Metastases in Subjects With Advanced Breast Cancer”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Study completedNCT00950911
What this trial is testing

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen 35
Testing effectiveness (Phase 2)Study completedNCT00104650
What this trial is testing

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast CancerBone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
Amgen 111
Large-scale testing (Phase 3)Study completedNCT00330759
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Who this might be right for
Bone Metastases
Amgen 1,779
Large-scale testing (Phase 3)Study completedNCT00321464
What this trial is testing

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Who this might be right for
Bone Metastases
Amgen 2,049
Testing effectiveness (Phase 2)Study completedNCT00091832
What this trial is testing

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasesBone Metastases in Subjects With Advanced Breast Cancer
Amgen 255
Large-scale testing (Phase 3)Study completedNCT01419717
What this trial is testing

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast Cancer
Amgen 129